Lexeo Therapeutics Ownership | Who Owns Lexeo Therapeutics?
Lexeo Therapeutics Ownership Summary
Lexeo Therapeutics is owned by 84.58% institutional investors, 0.75% insiders, and 14.67% retail investors. Opaleye management is the largest institutional shareholder, holding 0% of LXEO shares.
LXEO Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Lexeo Therapeutics | 84.58% | 0.75% | 14.67% |
Sector | Healthcare Stocks | 278.45% | 10.60% | -189.04% |
Industry | Biotech Stocks | 63.84% | 10.66% | 25.50% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Opaleye management | - | - | - |
Metlife investment management | - | - | - |
Nelson, van denburg & campbell wealth management group | - | - | - |
Rothschild investment | - | - | - |
Jane street group | - | - | - |
Gamma investing | - | - | - |
Altium capital management lp | - | - | - |
Aristides capital | - | - | - |
Walleye capital | - | - | - |
Wellington management group llp | - | - | - |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Opaleye management | - | - | - |
Metlife investment management | - | - | - |
Nelson, van denburg & campbell wealth management group | - | - | - |
Rothschild investment | - | - | - |
Jane street group | - | - | - |
Gamma investing | - | - | - |
Altium capital management lp | - | - | - |
Aristides capital | - | - | - |
Walleye capital | - | - | - |
Wellington management group llp | - | - | - |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Rothschild investment | - | - | -20.00 |
Nelson, van denburg & campbell wealth management group | - | - | -185.00 |
Gamma investing | - | - | -245.00 |
Russell investments group | - | - | -416.00 |
Skopos labs | - | - | -1.47K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Eventide asset management | - | - | -1.23M |
Altium capital management lp | - | - | -405.00K |
Opaleye management | - | - | -130.00K |
Wellington management group llp | - | - | -76.98K |
Walleye capital | - | - | -61.93K |
Sold Out
Holder | Change |
---|---|
Rothschild investment | -20.00 |
Nelson, van denburg & campbell wealth management group | -185.00 |
Gamma investing | -245.00 |
Russell investments group | -416.00 |
Skopos labs | -1.47K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Mar 31, 2025 | 91 | 4.60% | 28,007,979 | -3.59% | 84 | 1.10% | 42 | -26.32% | 23 | 109.09% |
Dec 31, 2024 | 89 | 32.84% | 29,519,159 | -0.73% | 89 | 1.10% | 59 | 13.46% | 11 | 37.50% |
Sep 30, 2024 | 67 | 17.54% | 29,735,114 | 11.93% | 89 | 1.39% | 52 | 33.33% | 8 | -38.46% |
Jun 30, 2024 | 57 | 5.56% | 26,566,626 | 14.91% | 80 | 1.18% | 39 | -15.22% | 13 | 160.00% |
Mar 31, 2024 | 54 | 74.19% | 23,119,893 | 42.94% | 82 | 2.24% | 46 | 48.39% | 5 | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
May 16, 2025 | Townsend Richard Nolan | Chief Executive Officer | Sell | $2.98K |
May 16, 2025 | Adler Eric | Chief Medical Officer | Sell | $1.62K |
May 16, 2025 | Robertson Jenny | Chief Legal Officer | Sell | $1.45K |
May 16, 2025 | See Tai Sandi | Chief Development Officer | Sell | $1.02K |
Feb 19, 2025 | Townsend Richard Nolan | Chief Executive Officer | Sell | $19.09K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q1 | - | 4 |
2024 Q4 | 1 | 3 |
2024 Q3 | - | 1 |
2023 Q4 | 2 | - |
LXEO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools